Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Expedio Hereditary Cancer Predisposition Screening Assay Kailos Genetics United States | 40 | 31 |
|
OnkoRisk Hereditary Oncology Management Panel BioReference Health United States | 47 | 17 |
|
OnkoRisk Hereditary Oncology Guideline Panel BioReference Health United States | 71 | 54 |
|
PathGroup United States | 13 | 1 |
|
Otogenetics Hereditary Cancers Otogenetics United States | 36 | 39 |
|
Microsatellite instability (MSI) GeneKor MSA Greece | 3 | 5 |
|
Myriad Genetics, Inc. United States | 32 | 46 |
|
Genome-Nilou Lab Iran | 45 | 34 |
|
GeneID Lab - Advanced Molecular Diagnostics United States | 41 | 19 |
|
Ambry Genetics United States | 79 | 37 |
|
Variant Resolution Test for CancerNext® 37 (+RNAinsight®) Ambry Genetics United States | 79 | 18 |
|
Variant Resolution Test for Penn Cancer Grant Panel (+RNAinsight®) Ambry Genetics United States | 79 | 18 |
|
Ambry Genetics United States | 79 | 80 |
|
Ambry Genetics United States | 35 | 20 |
|
Ambry Genetics United States | 35 | 18 |
|
Mismatch Repair Proteins by Immunohistochemistry GoPath Diagnostics United States | 6 | 4 |
|
Top 99 Genetic Causes of Developmental Delay Panel PreventionGenetics, part of Exact Sciences United States | 170 | 99 |
|
KRAS, BRAF, and NRA Mutation Analysis PathGroup United States | 23 | 3 |
|
BRAF and MSI Mutation Analysis PathGroup United States | 15 | 1 |
|
KRAS, BRAF, NRAS and MSI Mutation Analysis PathGroup United States | 23 | 3 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.